A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT07142421 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07142421
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-06
- Primary completion
- 2027-08-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.